Ani Pharmaceuticals Inc (ANIP)
Stock-Based Compensation
$21.60M
Quarterly · Period ending: · USD
ANIP Stock-Based Compensation
Latest reported$21.60Mperiod ending
Latest reported$21.60Mperiod ending
ANIP Quarterly Stock-Based Comp ($0.00 → $21.60M)
Quarterly stock-based compensation
High-resolution chart · PNG
ANIP stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 21,597,000 | |
| 0 | |
| 9,768,000 | |
| 9,691,000 | |
| 9,602,000 | |
| 8,868,000 | |
| 7,061,000 | |
| 7,484,000 | |
| 7,864,000 | |
| 6,934,000 | |
| 5,621,000 | |
| 5,444,000 | |
| 5,249,000 | |
| 4,338,000 | |
| 3,737,000 | |
| 3,869,000 | |
| 3,756,000 | |
| 3,237,000 | |
| 2,968,000 | |
| 2,808,000 | |
| 2,844,000 | |
| 1,869,000 | |
| 2,393,000 | |
| 2,383,000 | |
| 5,736,000 | |
| 2,424,000 | |
| 0 | |
| 2,470,000 | |
| 2,593,000 | |
| 1,710,000 | |
| 1,828,000 | |
| 1,795,000 | |
| 1,782,000 | |
| 1,377,000 | |
| 1,422,000 | |
| 1,475,000 | |
| 1,807,000 | |
| 1,386,000 | |
| 1,380,000 | |
| 1,365,000 | |
| 2,217,000 | |
| 1,105,000 | |
| 1,139,000 | |
| 1,120,000 | |
| 1,029,000 | |
| 568,000 | |
| 704,000 | |
| 693,000 | |
| 1,979,000 | |
| 47,000 | |
| 32,525 | |
| 3,000 | |
| 4,272,206 | |
| 145,794 | |
| -126,843 | |
| 270,002 | |
| 269,439 | |
| 313,027 | |
| 110,360 | |
| 305,162 | |
| 230,607 | |
| 350,795 | |
| 240,967 | |
| 325,349 | |
| 278,665 | |
| 204,971 | |
| 307,986 | |
| 305,199 | |
| 305,199 | |
| 336,119 | |
| 0 | |
| 0 | |
| 0 | |
| 258,775 | |
| 0 | |
| 0 | |
| 116,209 | |
| 220,798 | |
| 0 | |
| -49,203 | |
| -116,209 | |
| 859,013 | |
| 351,500,000 | |
| 0 | |
| 0 | |
| -402,568 | |
| 0 | |
| 0 | |
| 0 | |
| 293,916 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 18,000 | |
| 0 | |
| 0 | |
| 0 | |
| 18,000 | |
| 0 |